Conceptio
›
type-2-diabetes-mellitus
Topic
type-2-diabetes-mellitus
Knowledge-graph topic
· documents ABOUT type-2-diabetes-mellitus across the archive
970
Documents about type-2-diabetes-mellitus
Documents about type-2-diabetes-mellitus
The Effectivity and Safety Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus
#217002
ClinicalTrials.gov
Safety and Tolerability, Efficacy, Pharmacokinetic and Pharmacodynamic Study of Three Doses of BI 187004 Over 28 Days in Patients With Type 2 Diabetes Mellitus With and Without Metformin
#136289
ClinicalTrials.gov
Transition to Hospital Discharge in Insulinized Patients With Type 2 Diabetes Mellitus
#148722
ClinicalTrials.gov
Effect of Linagliptin on Insulin Sensitivity and Pancreatic Beta Cell Function in Patients With Type 2 Diabetes Mellitus
#195521
ClinicalTrials.gov
A Study to Assess the Efficacy and Safety of ASP1941 in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin
#267978
ClinicalTrials.gov
GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Pioglitazone
#18529
ClinicalTrials.gov
Efficacy/Safety of Vildagliptin and Metformin Combination Therapy in Patients With Type 2 Diabetes Not Well Controlled With Metformin Alone
#123409
ClinicalTrials.gov
Evaluation of Insulin Glargine/Lixisenatide Fixed Ratio Combination in Patients With Type 2 Diabetes Insufficiently Controlled With Oral Antidiabetic Drug(s)
#123420
ClinicalTrials.gov
Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With Thiazolidinedione Alone or Thiazolidinedione in Combination With Metformin
#126094
ClinicalTrials.gov
A Local Experiential Study With Sitagliptin (an Antihyperglycemic Drug) in 30 Patients With Type 2 Diabetes Mellitus (0431-178)
#146362
ClinicalTrials.gov
Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 Diabetes
#154865
ClinicalTrials.gov
Efficacy and Safety Of Different Regimens In Patients With Type 2 Diabetes Receiving Intensive Insulin Therapy
#175084
ClinicalTrials.gov
Vildagliptin 100 mg Once Daily vs. Placebo as add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin
#180343
ClinicalTrials.gov
The Impact of Semaglutide Compared to Energy Restriction on Type 2 Diabetes
#195497
ClinicalTrials.gov
Effect of Vitamin D on Inflammatory Markers in Type 2 Diabetes Mellitus in Mexico.
#201725
ClinicalTrials.gov
The Impact of Exercise Counseling on Exercise Behavior in People With Type 2 Diabetes: A Randomized Clinical Trial
#208377
ClinicalTrials.gov
Vildagliptin vs. Glibenclamide in Endothelial Function in Type 2 Diabetes and Hypertension
#221633
ClinicalTrials.gov
Long-term Safety Study of Alogliptin Used in Combination With Sulfonylurea or Metformin in Participants With Type 2 Diabetes in Japan
#226205
ClinicalTrials.gov
Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes
#230375
ClinicalTrials.gov
GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin
#230380
ClinicalTrials.gov
Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin
#234392
ClinicalTrials.gov
Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Metformin in Patients With Type 2 Diabetes
#249567
ClinicalTrials.gov
Patients With Heart Failure ANd Type 2 Diabetes Treated With Placebo Or Metformin (PHANTOM) Pilot Study
#249571
ClinicalTrials.gov
Efficacy of Vildagliptin 100 MG as Compared to Placebo as Add-on to Metformin in Patients With Type 2 Diabetes
#252966
ClinicalTrials.gov
A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin
#158175
ClinicalTrials.gov
Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic Agent
#201727
ClinicalTrials.gov
Safety and Efficacy of Liraglutide in Combination With an OAD in Subjects With Type 2 Diabetes Insufficiently Controlled on OAD Alone
#201751
ClinicalTrials.gov
Dietary intake of vegetables and type 2 diabetes prevention
#212000
Research Online
Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes
#160309
ClinicalTrials.gov
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
#18777
ClinicalTrials.gov
Evaluating the Impact of Year Long, Augmented Diabetes Self Management Support
#126054
ClinicalTrials.gov
Low-dose IL-2 in Established T1D - The "PROREG" Study
#158123
ClinicalTrials.gov
REASSURE: The Effect of Rimonabant on HbA1c in Overweight or Obese Patients With Type 2 Diabetes Not Adequately Controlled on 2 Oral Antidiabetic Agents
#140942
ClinicalTrials.gov
Effect of Linagliptin in Comparison With Glimepiride as Add on to Metformin on Postprandial Beta Cell Function, Postprandial Metabolism and Oxidative Stress in Patients With Type 2 Diabetes Mellitus
#180347
ClinicalTrials.gov
Specified Drug-Use Survey of Alogliptin and Metformin Hydrochloride Combination Tablets "Survey on Long-term Use in Type 2 Diabetes Mellitus Patients With Renal or Hepatic Impairment or Advanced Age"
#181722
ClinicalTrials.gov
Zinc supplementation for the prevention of type 2 diabetes mellitus in adults with insulin resistance
#215845
Repositório Institucional Unesp
Efficacy and Safety of Sotagliflozin Versus Placebo in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking Insulin Alone or With Other Oral Antidiabetic Agents
#226221
ClinicalTrials.gov
Proteomic signatures of early retinal neurodegeneration in type 2 diabetes mellitus
#251479
PLOS
12 Weeks Treatment With 3 Different Doses of BI 10773 in Type 2 Diabetic Patients
#18527
ClinicalTrials.gov
Comparison of Vildagliptin vs. Glimepiride on Glucose Variability in Metformin Uncontrolled Type 2 Diabetic Patients
#148698
ClinicalTrials.gov
Dose Comparisons of Leucine-Metformin Combinations on Blood Glucose Levels In Type 2 Diabetic Patients
#267970
ClinicalTrials.gov
Effects of Sequential Treatment Based on Lina/MET After Short-term Intensive Insulin in Newly Diagnosed Type 2 Diabetes
#123425
ClinicalTrials.gov
A Regulatory Requirement Non Interventional Study to Monitor Safety and Effectiveness of Trajenta Duo in Type 2 Diabetes Patients in Korea
#126066
ClinicalTrials.gov
Association of AGTR1 and ACACB Gene Polymorphism and Diabetic Nephropathy in Type 2 Diabetes
#127749
ClinicalTrials.gov
Central Insulin Sensitivity in Individuals With Type 2 Diabetes (T2D) and at Risk for Developing T2D
#146349
ClinicalTrials.gov
A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients
#146379
ClinicalTrials.gov
GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin
#154863
ClinicalTrials.gov
Safety, Tolerability and Renal Effects of APX-115 in Subjects With Type 2 Diabetes and Nephropathy
#160268
ClinicalTrials.gov
Efficacy and Safety of Empagliflozin (BI 10773) in Type 2 Diabetes Patients on a Background of Pioglitazone Alone or With Metformin
#162417
ClinicalTrials.gov
Safety and Efficacy of PB-119 in Subjects With Type 2 Diabetes and Not Well-controlled by Metformin Monotherapy
#180279
ClinicalTrials.gov
← Previous
Page 10 of 20
Next →
Topic record
· derived from the Conceptio knowledge graph (shared subject terms across the corpus)
Conceptio Open Knowledge Archive — topic hubs link to canonical document pages with full provenance.